Skip to content

Effect of persian medicine dietary recommendations in kidney stone

Evaluation the effect of Iranian Traditional Medicine (Persian Medicine) dietary recommendations on metabolic risk factors in calcium or radio-opaque kidney stones: a controlled randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190928044906N1
Enrollment
80
Registered
2019-11-11
Start date
2019-11-21
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet in nephrolithiasis. Calculus of kidney

Interventions

Intervention 1: Intervention group: Diet based on traditional Iranian medicine books and scientists such as Ibn Sina to control recurrence of stone and improve urinary supersaturation of calcium oxal

Sponsors

Research deputy of Shahid Beheshti School of Traditional medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Non-pregnant and non-lactating women Men Patients referred to the Stone Prevention Clinic of Labbafinejad Hospital which can perform tests and follow-up to implement the plan People with calcium stone or Patients with Radioopacitis stone in radiology At least once the recurrence of the stone. Are not under the special regime to prevent kidney stones, At least 20 days have passed since their last treatment interventions. 18 to 65 years old

Exclusion criteria

Exclusion criteria: GFR less than 60 24-hour urinary oxalate above 40 mg Which changed to over 60mg Taking drugs affecting calcium metabolism such as calcium supplements Taking oxalate or supresturation modifier drugs like vitamin B6, magnesium, potassium citrate, allopurinol liver failure diseases, diabetes, hyperthyroid, hyperparathyroid disease, immunopathogenic diseases, cancer, chronic diarrhea, chronic kidney failure and urinary tract infection Taking anti-obesity drugs to absorb fat-soluble inhibitors such as: Orlistate Taking herbal medicines less than a month before studying or during the study Pregnant and lactating women Added condition: Do not change the dose of blood pressure medication one month before the plan and during the plan

Design outcomes

Primary

MeasureTime frame
24-hour urinary calcium oxalate supersaturation. Timepoint: The beginning of the study and the end of the two-month diet. Method of measurement: Litorsk Software.;24-hour urinary uric acid supersaturation. Timepoint: The beginning of the study and the end of the two-month diet. Method of measurement: Litorsk Software.;24-hour urinary calcium phosphate supersaturation. Timepoint: The beginning of the study and the end of the two-month diet. Method of measurement: Litorsk Software.

Secondary

MeasureTime frame
Evaluate foods eaten (Food recall). Timepoint: The beginning and the end of the study. Method of measurement: Nutrition 4 software.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Kargarsharif

Shahid Beheshti University of Medical Sciences

f.kargarsharif@sbmu.ac.ir+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026